Summary
- Current Price
- As of today, PYXS price is $2.23, up +2.76% on
- Current Price All-Time High
- PYXS price is currently -88.26% below its historical high of $19.00 set on
- Market Cap
- PYXS current market cap is $141M, up +79.09% over the past 365 days
- PE Ratio
- PYXS PE ratio is unknown
- Revenue
- PYXS current annual revenue is $13.86M, down -14.17% year-over-year
- Next Earnings
- The next earnings release for PYXS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Pyxis Oncology, Inc. |
| Ticker | NASDAQ: PYXS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pyxisoncology.com |
| Employees | 44 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.23 | ||
| Price, 1D Change | +2.76% | |
| $141M | ||
| - | ||
| - | ||
| 1.25 | ||
| $14M | ||
| Revenue, 1Y Change | -14.17% | |
| -$1.28 | ||
| EPS, 1Y Change | +3.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.28 | ||
| EPS Estimate | N/A | -$1.23 |
| EPS Est. Change | N/A | +4.39% |
| $13.86M | ||
| Revenue Estimate | N/A | $43.75K |
| Revenue Est. Change | N/A | -99.68% |
| $2.23 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +213.90% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.09 | -$1.32 | -21.23% | |
| -$1.31 | -$1.28 | +2.28% | |
| -$1.23 | N/A | +4.39% | |
| -$1.24 | N/A | +3.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.80M | $16.15M | +17.01% | |
| $2.16M | $13.86M | +542.32% | |
| $43.75K | N/A | -99.68% | |
| $3.13M | N/A | -77.45% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +74.22% | ||
| -16.17% | ||
| +79.09% | ||
| +43.87% | ||
| -14.17% | ||
| +100.00% | ||
| +3.17% | ||
| +64.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.23 | ||
| $2.30 | ||
| $1.92 | ||
| $1.97 | ||
| $1.88 | ||
| $0.07 | ||
| 1.25 | ||
| $0.20 | ||
| 66.00 | ||
| 54.70% | ||
| 118.20% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $13.86M | ||
| -$1.28 | ||
| $6.96M | ||
| 50.22% | ||
| -$84.42M | ||
| -609.18% | ||
| -$79.62M | ||
| -574.55% | ||
| -$79.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.35 | ||
| 3.41 | ||
| 3.41 | ||
| - | ||
| - | ||
| -6.66 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 10.20 | ||
| 4.52 | ||
| -1.44 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $53.41M | ||
| $68.33M | ||
| $94.52M | ||
| $72.11M | ||
| $41.11M | ||
| $21.13M | ||
| $18.67M | ||
| $1.69M | ||
| $10.89M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $93.48M | ||
| $91.38M | ||
| $6.90M | ||
| $0.00 | ||
| $4.51M | ||
| $0.00 | ||
| $1.39M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$63.50M | ||
| $58.86M | ||
| $594.00K | ||
| $9,000.00 | ||
| -$63.51M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | ||
| Stifel | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Stephens & Co. | → | |
| Guggenheim | → | |
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PYXS
FAQ
What is the ticker symbol for Pyxis Oncology, Inc.?
The ticker symbol for Pyxis Oncology, Inc. is NASDAQ:PYXS
Does Pyxis Oncology, Inc. pay dividends?
No, Pyxis Oncology, Inc. does not pay dividends
What sector is Pyxis Oncology, Inc. in?
Pyxis Oncology, Inc. is in the Healthcare sector
What industry is Pyxis Oncology, Inc. in?
Pyxis Oncology, Inc. is in the Biotechnology industry
What country is Pyxis Oncology, Inc. based in?
Pyxis Oncology, Inc. is headquartered in United States
When did Pyxis Oncology, Inc. go public?
Pyxis Oncology, Inc. initial public offering (IPO) was on October 8, 2021
Is Pyxis Oncology, Inc. in the S&P 500?
No, Pyxis Oncology, Inc. is not included in the S&P 500 index
Is Pyxis Oncology, Inc. in the NASDAQ 100?
No, Pyxis Oncology, Inc. is not included in the NASDAQ 100 index
Is Pyxis Oncology, Inc. in the Dow Jones?
No, Pyxis Oncology, Inc. is not included in the Dow Jones index
When was Pyxis Oncology, Inc. last earnings report?
Pyxis Oncology, Inc.'s most recent earnings report was on May 14, 2026
When does Pyxis Oncology, Inc. report earnings?
The next expected earnings date for Pyxis Oncology, Inc. is August 13, 2026
Data Sources & References
- PYXS Official Website www.pyxisoncology.com
- PYXS Profile on Yahoo Finance finance.yahoo.com/quote/PYXS
- PYXS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pyxs